{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:47:50Z","timestamp":1771649270352,"version":"3.50.1"},"reference-count":37,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T-cell tolerance is mandatory for major histocompatibility complex (MHC)-mismatched stem-cell transplantation without cytoreduction. Here, we used a cytotoxicity assay based on the infusion of differentially carboxyfluorescein succinimidyl ester (CFSE)-labeled syngeneic and donor splenocytes to determine the survival of donor cells in vivo. In vivo cytotoxicity data showed that treatment with anti-CD40 ligand monoclonal antibody in combination with a low dose of MHC-mismatched bone marrow cells was sufficient to induce T-cell tolerance. However, CFSE-labeled donor cells were still eliminated. A similar elimination pattern was observed in T-cell and natural killer T-cell (NKT-cell)-deficient mice, suggesting the involvement of natural killer (NK) cells. Indeed, in vivo NK-cell depletion resulted in a prolonged survival of CFSE-labeled donor cells, confirming the role of NK cells in this process. Transplantation of a megadose of MHC-mismatched bone marrow cells was required for a complete survival of CFSE-labeled donor cells. This NK-cell tolerance was donor specific and was associated with mixed chimerism. Additional NK-cell depletion significantly enhanced engraftment and allowed long-term chimerism after transplantation of a relatively low dose of donor bone marrow cells. These data demonstrate the importance of NK cells in the rejection of MHC-mismatched hematopoietic cells and may explain the high numbers of bone marrow cells required for transplantation over MHC barriers. (Blood. 2005;106:2215-2220)<\/jats:p>","DOI":"10.1182\/blood-2005-04-1391","type":"journal-article","created":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T02:48:54Z","timestamp":1117594134000},"page":"2215-2220","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":64,"title":["Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance"],"prefix":"10.1182","volume":"106","author":[{"given":"Geert","family":"Westerhuis","sequence":"first","affiliation":[{"name":"From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy G. E.","family":"Maas","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roel","family":"Willemze","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene\u0301 E. M.","family":"Toes","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem E.","family":"Fibbe","sequence":"additional","affiliation":[{"name":"From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021219124052000_REF1","unstructured":"Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. Clin Transpl.2003; 275-282."},{"key":"2020021219124052000_REF2","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Parkman R, Walters MC. Bone marrow transplantation for non-malignant disease. Hematology (Am Soc Hematol Educ Program).2000; 319-338.","DOI":"10.1182\/asheducation.V2000.1.319.20000319"},{"key":"2020021219124052000_REF3","doi-asserted-by":"crossref","unstructured":"Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol.2004;5: 996-1002.","DOI":"10.1038\/ni1114"},{"key":"2020021219124052000_REF4","doi-asserted-by":"crossref","unstructured":"Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol.2003;3: 304-316.","DOI":"10.1038\/nri1055"},{"key":"2020021219124052000_REF5","doi-asserted-by":"crossref","unstructured":"Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol.2001;1: 41-49.","DOI":"10.1038\/35095564"},{"key":"2020021219124052000_REF6","doi-asserted-by":"crossref","unstructured":"Murphy WJ, Koh CY, Raziuddin A, Bennett M, Longo DL. Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev.2001;181: 279-289.","DOI":"10.1034\/j.1600-065X.2001.1810124.x"},{"key":"2020021219124052000_REF7","doi-asserted-by":"crossref","unstructured":"Tiberghien P, Longo DL, Wine JW, Alvord WG, Reynolds CW. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood.1990;76: 1419-1430.","DOI":"10.1182\/blood.V76.7.1419.1419"},{"key":"2020021219124052000_REF8","doi-asserted-by":"crossref","unstructured":"Cho SG, Shuto Y, Soda Y, et al. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation. Exp Hematol.2004;32: 1246-1254.","DOI":"10.1016\/j.exphem.2004.08.008"},{"key":"2020021219124052000_REF9","doi-asserted-by":"crossref","unstructured":"Chargui J, Oyama A, Yoshimura R, Wada S, Hase T, Kishimoto T. Inhibition of NK cell activity induces improvement and stable chimerism after allogeneic transplantation. Transplant Proc.2000;32: 2462-2463.","DOI":"10.1016\/S0041-1345(00)01744-9"},{"key":"2020021219124052000_REF10","doi-asserted-by":"crossref","unstructured":"Aguila HL, Weissman IL. Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood.1996;87: 1225-1231.","DOI":"10.1182\/blood.V87.4.1225.bloodjournal8741225"},{"key":"2020021219124052000_REF11","doi-asserted-by":"crossref","unstructured":"Lee LA, Sergio JJ, Sykes M. Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells. Transplantation.1996;61: 125-132.","DOI":"10.1097\/00007890-199601150-00024"},{"key":"2020021219124052000_REF12","doi-asserted-by":"crossref","unstructured":"Pellicci DG, Hammond KJ, Uldrich AP, Baxter AG, Smyth MJ, Godfrey DI. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med.2002;195: 835-844.","DOI":"10.1084\/jem.20011544"},{"key":"2020021219124052000_REF13","doi-asserted-by":"crossref","unstructured":"Bancroft GJ, Shellam GR, Chalmer JE. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol.1981;126: 988-994.","DOI":"10.4049\/jimmunol.126.3.988"},{"key":"2020021219124052000_REF14","doi-asserted-by":"crossref","unstructured":"Grundy JE, Melief CJ. Effect of Nu\/Nu gene on genetically determined resistance to murine cytomegalovirus. J Gen Virol.1982;61(pt l): 133-136.","DOI":"10.1099\/0022-1317-61-1-133"},{"key":"2020021219124052000_REF15","unstructured":"Shizuru JA, Jerabek L, Edwards CT, Weissman IL. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol Blood Marrow Transplant.1996;2: 3-14."},{"key":"2020021219124052000_REF16","doi-asserted-by":"crossref","unstructured":"Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med.2000;6: 464-469.","DOI":"10.1038\/74731"},{"key":"2020021219124052000_REF17","doi-asserted-by":"crossref","unstructured":"Durham MM, Bingaman AW, Adams AB, et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol.2000;165: 1-4.","DOI":"10.4049\/jimmunol.165.1.1"},{"key":"2020021219124052000_REF18","doi-asserted-by":"crossref","unstructured":"Seung E, Mordes JP, Rossini AA, Greiner DL. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J Clin Invest.2003;112: 795-808.","DOI":"10.1172\/JCI18599"},{"key":"2020021219124052000_REF19","doi-asserted-by":"crossref","unstructured":"Graca L, Le Moine A, Lin CY, Fairchild PJ, Cobbold SP, Waldmann H. Donor-specific transplantation tolerance: the paradoxical behavior of CD4+CD25+ T cells. Proc Natl Acad Sci U S A.2004;101: 10122-10126.","DOI":"10.1073\/pnas.0400084101"},{"key":"2020021219124052000_REF20","doi-asserted-by":"crossref","unstructured":"Tanaka T, Tsudo M, Karasuyama H, et al. A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol.1991;147: 2222-2228.","DOI":"10.4049\/jimmunol.147.7.2222"},{"key":"2020021219124052000_REF21","doi-asserted-by":"crossref","unstructured":"Tanaka T, Kitamura F, Nagasaka Y, Kuida K, Suwa H, Miyasaka M. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J Exp Med.1993;178: 1103-1107.","DOI":"10.1084\/jem.178.3.1103"},{"key":"2020021219124052000_REF22","doi-asserted-by":"crossref","unstructured":"Ehl S, Nuesch R, Tanaka T, Myasaka M, Hengartner H, Zinkernagel R. A comparison of efficacy and specificity of three NK depleting antibodies. J Immunol Methods.1996;199: 149-153.","DOI":"10.1016\/S0022-1759(96)00175-5"},{"key":"2020021219124052000_REF23","doi-asserted-by":"crossref","unstructured":"Brecher G, Ansell JD, Micklem HS, Tjio JH, Cronkite EP. Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice. Proc Natl Acad Sci U S A.1982;79: 5085-5087.","DOI":"10.1073\/pnas.79.16.5085"},{"key":"2020021219124052000_REF24","doi-asserted-by":"crossref","unstructured":"Boggs DR. The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol.1984;16: 277-286.","DOI":"10.1002\/ajh.2830160309"},{"key":"2020021219124052000_REF25","doi-asserted-by":"crossref","unstructured":"Dahlke MH, Lauth OS, Jager MD, et al. In vivo depletion of hematopoietic stem cells in the rat by an anti-CD45 (RT7) antibody. Blood.2002;99: 3566-3572.","DOI":"10.1182\/blood.V99.10.3566"},{"key":"2020021219124052000_REF26","doi-asserted-by":"crossref","unstructured":"Colucci F, Di Santo JP, Leibson PJ. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol.2002;3: 807-813.","DOI":"10.1038\/ni0902-807"},{"key":"2020021219124052000_REF27","doi-asserted-by":"crossref","unstructured":"Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol.2001;19: 291-330.","DOI":"10.1146\/annurev.immunol.19.1.291"},{"key":"2020021219124052000_REF28","doi-asserted-by":"crossref","unstructured":"Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature.1992;358: 66-70.","DOI":"10.1038\/358066a0"},{"key":"2020021219124052000_REF29","doi-asserted-by":"crossref","unstructured":"Daniels BF, Nakamura MC, Rosen SD, Yokoyama WM, Seaman WE. Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain. Immunity.1994;1: 785-792.","DOI":"10.1016\/S1074-7613(94)80020-0"},{"key":"2020021219124052000_REF30","doi-asserted-by":"crossref","unstructured":"Kane KP. Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules. J Exp Med.1994;179: 1011-1015.","DOI":"10.1084\/jem.179.3.1011"},{"key":"2020021219124052000_REF31","doi-asserted-by":"crossref","unstructured":"Nakamura MC, Linnemeyer PA, Niemi EC, et al. Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med.1999;189: 493-500.","DOI":"10.1084\/jem.189.3.493"},{"key":"2020021219124052000_REF32","doi-asserted-by":"crossref","unstructured":"George TC, Ortaldo JR, Lemieux S, Kumar V, Bennett M. Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol.1999;163: 1859-1867.","DOI":"10.4049\/jimmunol.163.4.1859"},{"key":"2020021219124052000_REF33","doi-asserted-by":"crossref","unstructured":"Manilay JO, Waneck GL, Sykes M. Altered expression of Ly-49 receptors on NK cells developing in mixed allogeneic bone marrow chimeras. Int Immunol.1998;10: 1943-1955.","DOI":"10.1093\/intimm\/10.12.1943"},{"key":"2020021219124052000_REF34","doi-asserted-by":"crossref","unstructured":"Zhao Y, Ohdan H, Manilay JO, Sykes M. NK cell tolerance in mixed allogeneic chimeras. J Immunol.2003;170: 5398-5405.","DOI":"10.4049\/jimmunol.170.11.5398"},{"key":"2020021219124052000_REF35","doi-asserted-by":"crossref","unstructured":"Welsh RM, Markees TG, Woda BA, et al. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol.2000;74: 2210-2218.","DOI":"10.1128\/JVI.74.5.2210-2218.2000"},{"key":"2020021219124052000_REF36","doi-asserted-by":"crossref","unstructured":"Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest.2003;111: 1887-1895.","DOI":"10.1172\/JCI200317477"},{"key":"2020021219124052000_REF37","doi-asserted-by":"crossref","unstructured":"Taylor DK, Neujahr D, Turka LA. Heterologous immunity and homeostatic proliferation as barriers to tolerance. Curr Opin Immunol.2004;16: 558-564.","DOI":"10.1016\/j.coi.2004.07.007"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/6\/2215\/1635132\/zh801805002215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/6\/2215\/1635132\/zh801805002215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T09:08:17Z","timestamp":1683104897000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/6\/2215\/21637\/Longterm-mixed-chimerism-after-immunologic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,15]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-04-1391","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,15]]}}}